Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Drug Interactions
100%
HIV Infection
100%
Erectile Dysfunction
100%
Phosphodiesterase Type V Inhibitors
100%
Antiretroviral Therapy
41%
Phosphodiesterase Type 5 Inhibitors
25%
PDE5 Inhibitors
25%
Boosted Protease Inhibitors
16%
Multivariate Analysis
8%
African American
8%
Inclusion Criteria
8%
Logistic Regression Analysis
8%
Major Depressive Disorder
8%
Protease Inhibitors
8%
Atazanavir
8%
US Military
8%
Antiretroviral Therapy Regimens
8%
Multiple Drugs
8%
Darunavir
8%
Episode Duration
8%
Drug Information Resources
8%
Natural History Study
8%
Elvitegravir
8%
Vardenafil
8%
Sildenafil
8%
Potential Drug-drug Interactions
8%
Tadalafil
8%
Pharmacology, Toxicology and Pharmaceutical Science
Drug-Drug Interaction
100%
Human Immunodeficiency Virus Infection
100%
Drug Interaction
100%
Phosphodiesterase V Inhibitor
100%
Erectile Dysfunction
100%
Proteinase Inhibitor
25%
Phosphodiesterase V
25%
Prevalence
16%
HIV
8%
Major Depression
8%
Darunavir
8%
Atazanavir
8%
Sildenafil
8%
Vardenafil
8%
Elvitegravir
8%
Tadalafil
8%
Drug Information
8%
Medicine and Dentistry
Human Immunodeficiency Virus Infection
100%
Drug Interaction
100%
Phosphodiesterase V Inhibitor
100%
Erectile Dysfunction
100%
Antiretroviral Therapy
46%
Proteinase Inhibitor
23%
Phosphodiesterase V
23%
Prevalence
15%
Logistic Regression Analysis
7%
Human Immunodeficiency Virus
7%
Study Participant
7%
Major Depressive Episode
7%
Darunavir
7%
Sildenafil
7%
Vardenafil
7%
Tadalafil
7%
Atazanavir
7%
Elvitegravir
7%
Primary Outcome
7%
Multivariate Analysis
7%
Neuroscience
Human Immunodeficiency Virus
100%
Phosphodiesterase V
100%
Drug Interaction
100%
Proteinase
23%
Major Depressive Disorder
7%
Darunavir
7%
Atazanavir
7%
Elvitegravir
7%
Tadalafil
7%
Vardenafil
7%
Sildenafil
7%
Immunology and Microbiology
Human Immunodeficiency Virus Infection
100%
Drug Interaction
100%
Drug-Drug Interaction
100%
Prevalence
16%
Human Immunodeficiency Virus
8%